RCE looks like a good buy in the next couple of weeks. EOFY tax selling is killing the SP, but reality is, this is all artificial relative to what the Company is actually doing and the successes it has had. Any large pharma with an eye on this or any other biotech thats being sold off would be looking to make a low ball offer around June each year
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 30.8¢ | $19.58K | 62.05K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 18944 | 3 |
View Market Depth
| Last trade - 12.43pm 27/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |